China · Delayed Price · Currency is CNY Nanjing Vazyme Biotech Statistics
Total Valuation
SHA:688105 has a market cap or net worth of CNY 14.08 billion. The enterprise value is 12.24 billion.
| Market Cap | 14.08B |
| Enterprise Value | 12.24B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
SHA:688105 has 516.99 million shares outstanding. The number of shares has increased by 39.58% in one year.
| Current Share Class | 516.99M |
| Shares Outstanding | 516.99M |
| Shares Change (YoY) | +39.58% |
| Shares Change (QoQ) | -25.23% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 9.88% |
| Float | 175.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 131.97 |
| PS Ratio | 9.57 |
| PB Ratio | 3.91 |
| P/TBV Ratio | 4.14 |
| P/FCF Ratio | 65.15 |
| P/OCF Ratio | 55.15 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 56.60 |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.99 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 17.26 |
| Debt / FCF | 3.11 |
| Interest Coverage | -4.21 |
Financial Efficiency
Return on equity (ROE) is -0.50% and return on invested capital (ROIC) is -5.23%.
| Return on Equity (ROE) | -0.50% |
| Return on Assets (ROA) | -1.20% |
| Return on Invested Capital (ROIC) | -5.23% |
| Return on Capital Employed (ROCE) | -2.50% |
| Weighted Average Cost of Capital (WACC) | 7.76% |
| Revenue Per Employee | 490,377 |
| Profits Per Employee | -2,925 |
| Employee Count | 3,002 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | -12.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.70% in the last 52 weeks. The beta is 0.68, so SHA:688105's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +53.70% |
| 50-Day Moving Average | 21.46 |
| 200-Day Moving Average | 17.19 |
| Relative Strength Index (RSI) | 67.70 |
| Average Volume (20 Days) | 13,317,513 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688105 had revenue of CNY 1.47 billion and -8.78 million in losses. Loss per share was -0.02.
| Revenue | 1.47B |
| Gross Profit | 980.46M |
| Operating Income | -94.79M |
| Pretax Income | -31.65M |
| Net Income | -8.78M |
| EBITDA | -5.44M |
| EBIT | -94.79M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 2.51 billion in cash and 671.57 million in debt, with a net cash position of 1.84 billion or 3.56 per share.
| Cash & Cash Equivalents | 2.51B |
| Total Debt | 671.57M |
| Net Cash | 1.84B |
| Net Cash Per Share | 3.56 |
| Equity (Book Value) | 3.60B |
| Book Value Per Share | 6.98 |
| Working Capital | 2.53B |
Cash Flow
In the last 12 months, operating cash flow was 255.35 million and capital expenditures -39.19 million, giving a free cash flow of 216.16 million.
| Operating Cash Flow | 255.35M |
| Capital Expenditures | -39.19M |
| Depreciation & Amortization | 89.35M |
| Net Borrowing | -545.52M |
| Free Cash Flow | 216.16M |
| FCF Per Share | 0.42 |
Margins
Gross margin is 66.60%, with operating and profit margins of -6.44% and -0.60%.
| Gross Margin | 66.60% |
| Operating Margin | -6.44% |
| Pretax Margin | -2.15% |
| Profit Margin | -0.60% |
| EBITDA Margin | -0.37% |
| EBIT Margin | -6.44% |
| FCF Margin | 14.68% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 1.41%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 1.41% |
| Dividend Growth (YoY) | 261.12% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | 119.59% |
| Buyback Yield | -39.58% |
| Shareholder Yield | -38.17% |
| Earnings Yield | -0.06% |
| FCF Yield | 1.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SHA:688105 is 21.30, which is -21.81% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 21.30 |
| Price Target Difference | -21.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 18.35% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 3, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:688105 has an Altman Z-Score of 6.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.2 |
| Piotroski F-Score | 4 |